Skip to main content
Clinical Trials/NCT02345811
NCT02345811CompletedNot Applicable

A Bilateral Dispensing Clinical Trial of Sapphire Lens Against Senofilcon A Lens Over 2 Weeks

Coopervision, Inc.2 sites in 2 countries34 target enrollmentStarted: January 1, 2015Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
34
Locations
2
Primary Endpoint
Vision Quality

Study Overview

Brief Summary

To evaluate the clinical performance of an investigational silicone-hydrogel lens when worn on a daily wear modality over two weeks of lens wear.

Detailed Description

This was a randomized, bilateral, 2 week cross over, double-masked, dispensing study comparing Sapphire test lens against the senofilcon A control lens. This study results were not used to support design validation of the test lens.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
17 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Is at least 17 years of age for Canada and 18 years of age for the USA and has full legal capacity to volunteer
  • •Has read and signed an information consent letter
  • •Is willing and able to follow instructions and maintain the appointment schedule;
  • •Is an adapted soft contact lens wearer
  • •Requires spectacle lens powers between -0.50 to -6.00 diopters sphere (0.25D steps) or +1.00 to +8.00 diopters sphere (1.00D steps)
  • •Has no more than 0.75 diopters of refractive astigmatism
  • •Willing to wear contact lens in both eyes
  • •Has manifest refraction visual acuities (VA) equal to or better than logMAR equivalent of 20/25 in each eye
  • •To be eligible for lens dispensing, the subject must have VA of logMAR equivalent of 20/30 or better in each eye with the study lenses and the investigator must judge the fit as acceptable

Exclusion Criteria

  • •Is participating in any concurrent clinical or research study
  • •Has any known active* ocular disease and/or infection
  • •Has a systemic condition that in the opinion of the investigator may affect a study outcome variable
  • •Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable
  • •Has known sensitivity to the diagnostic pharmaceuticals to be used in the study
  • •Is pregnant, lactating or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit)
  • •Is aphakic
  • •Has undergone refractive error surgery

Arms & Interventions

Sapphire

Experimental

Participants were randomized to wear the Sapphire lens pair for two weeks during the cross over study.

Intervention: Sapphire (Device)

senofilcon A

Active Comparator

Participants were randomized to wear the senofilcon A lens pair for two weeks during the cross over study.

Intervention: senofilcon A (Device)

Outcomes

Primary Outcomes

Vision Quality

Time Frame: 2 weeks - End of Day

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Surface Deposits

Time Frame: 2-weeks

Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)

Lens Handling (Ease of Insertion)

Time Frame: 2 weeks

Lens handling - ease of insertion of the lenses. Scale 0-100, 0=could not place lens on eye, 100=always easy to place lens on eye.

Lens Handling (Ease of Removal)

Time Frame: 2 weeks

Lens handling - ease of removal of the lenses. Scale 0-100, 0=could not remove lens from eye, 100=always easy to remove lens from eye.

Subjective Rating for Comfort.

Time Frame: 2-weeks - End of Day

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Subjective Preference for Comfort.

Time Frame: 2 weeks

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Lens Surface Wettability

Time Frame: 2 weeks

Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)

Vision Quality

Time Frame: Baseline (10 minutes post lens settling at dispense)

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Vision Quality

Time Frame: 2 weeks - During the Day

Subjective rating for vision quality. Collected at dispense after settling of each study pair. (0-100 scale; 0=extremely poor vision, 100=excellent vision)

Subjective Rating for Comfort.

Time Frame: Baseline - 10 minutes post lens settling

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Subjective Rating for Comfort.

Time Frame: 2-weeks - During the Day

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Lens Surface Wettability

Time Frame: Baseline (10 minutes post lens settling)

Lens surface wettability assessed. Scale 0-4, 0.25 steps, 0=nonwetting, 4=excellent)

Surface Deposits

Time Frame: Baseline (10 minutes post lens settling)

Surface deposits is assessed. (Scale 0-4,0.25 steps) (0=no deposits; 1 = \<5 deposits; 2 = \>5 deposits or film 25-50% of surface; 3 = deposits 0.1 - 0.5mm or film 50-75% of surface; 4 = deposits \>0.5mm or film \> 75% of surface)

Subjective Preference for Comfort.

Time Frame: Baseline - 10 minutes post lens settling

Subjective rating for comfort. Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials